Join us to learn more about “Early Drug Development Programs: The Need for Translational Medicine and Proven Regulatory Strategies”.

Attendees learn more about the role of translational medicine in a drug development program, preparation of a successful IND package, and preparation for a successful pre-IND meeting.

Luana Pesco Koplowitz received her MD from Rutgers Medical School and her Ph.D. from Rutgers College of Pharmacy and Columbia Pacific University. She is a fellow of the American College of Clinical Pharmacology and also a member and fellow of the Faculty of Pharmaceutical Medicine of the United Kingdom. Dr. Pesco Koplowitz works with multiple pharmaceutical and biotechnology companies in the fields of nonclinical development, translational medicine, clinical pharmacology, and regulatory strategy. To learn more about Dr. Pesco Koplowitz, please visit our Scientific Advisory Board page on our website.

Register here – https://app.livestorm.co/clinilabs-drug-development-corporation/early-drug-development-programs-the-need-for-translational-medicine-and-proven-regulatory-strategie

Spaces are limited. Reserve your spot today!